Location History:
- Irvington, NY (US) (2002 - 2005)
- New York, NY (US) (1995 - 2011)
Company Filing History:
19 out of 2,489 
3 out of 832,880 Years Active: 1995-2011
Title: Patrick S. Moore: A Pioneer in KSHV Research and Patent Innovation
Introduction
Patrick S. Moore is a notable inventor based in New York, NY, who has made significant contributions to the field of virology with a focus on Kaposi's sarcoma-associated herpesvirus (KSHV). With a total of 22 patents to his name, Moore's work has advanced our understanding of viral genetics and its implications in cancer research.
Latest Patents
Among his most recent patents, two stand out due to their innovative approaches to understanding and potentially treating KSHV. The first patent, titled "Unique associated Kaposi's sarcoma virus sequences and uses thereof," introduces an isolated peptide encoded by a nucleic acid sequence that uniquely identifies a herpesvirus linked to Kaposi's sarcoma. This virus is recoverable from the HBL-6 cell line, opening avenues for further research and therapeutic applications.
The second notable patent, "Spliced gene of KSHV/HHV8, its promoter and monoclonal antibodies specific for LANA2," offers an isolated nucleic acid that encodes the latency-associated nuclear antigen 2 polypeptide (LANA2) of KSHV. This innovation includes the characterization of a specific promoter for LANA2 transcription and proposes methods to inhibit p53-mediated apoptosis, alongside a novel approach for producing antibodies against this critical antigen.
Career Highlights
Patrick S. Moore has been associated with prestigious institutions such as Columbia University in the City of New York. His tenure at this institution has fortified his research efforts in the field of cancer virology, leading to impactful innovations and patents that have potential implications for medical science.
Collaborations
Throughout his career, Moore has collaborated with esteemed colleagues, including Yuan Chang and Roy A. Bohenzky. These partnerships have played a crucial role in his research and development, facilitating breakthroughs in understanding the genetic mechanisms of KSHV and its role in diseases.
Conclusion
In conclusion, Patrick S. Moore's contributions to the field of KSHV research and his impressive portfolio of patents exemplify the intersection of scientific inquiry and innovation. His ongoing work continues to inspire future research that may lead to advancements in cancer treatment and understanding viral mechanisms.